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Abstract
A massive and selective loss of CD4+ memory T cells occurs during the acute phase of immunodeficiency virus infections.
The mechanism of this depletion is poorly understood but constitutes a key event with implications for progression. We
assessed gene expression of purified T cells in Rhesus Macaques during acute SIVmac239 infection in order to define
mechanisms of pathogenesis. We observe a general transcriptional program of over 1,600 interferon-stimulated genes
induced in all T cells by the infection. Furthermore, we identify 113 transcriptional changes that are specific to virally
infected cells. A striking downregulation of several key cell cycle regulator genes was observed and shared promotor-region
E2F binding sites in downregulated genes suggested a targeted transcriptional control of an E2F regulated cell cycle
program. In addition, the upregulation of the gene for the fundamental regulator of RNA polymerase II, TAF7, demonstrates
that viral interference with the cell cycle and transcriptional regulation programs may be critical components during the
establishment of a pathogenic infection in vivo.
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Introduction
The CD4+ memory T cell compartment is the primary target
o fH I Vi nh u m a n sa n do fS I Vi nn o n h u m a np r i m a t e s( N H P ) ;
the destruction of this critical subset sets the stage for the
pathogenic events leading to AIDS [1]. The targeted loss of
CD4+ memory cells occurs in multiple tissues during the acute
phase of infection [2,3], and this loss, especially affecting cells in
gut associated mucosal tissue, strongly impacts the long-term
outcome of viral infection. Indeed, for NHP, the extent of
memory cell destruction during the acute phase predicts long-
term survival. This assault on the adaptive immune system not
only affects the antigen specific immune responses but also the
mucosa associated immune function, i.e., the control of mucosal
barrier integrity and the subsequent immune activation by
microbial byproducts [4,5,6]. Thus, the protection of the
immediate CD4+ memory T cell functions is one of the key
elements of HIV vaccines [7,8].
As have been demonstrated by several studies [2,3,4,6] a
selective and massive loss of infected CD4+ memory T cells occurs
during the acute phase of infection. The mechanism of this
depletion is poorly understood: given the extent of the destruction,
even resting memory T cells that are not postulated to support
productive viral replication are depleted. To explore the range of
virus-induced cellular changes that might explain cell death even
in the absence of T cell activation-induced viral replication, we
assessed the transcriptional events that occur in vivo just prior to
and during the peak of viremia after infection with SIV. Using the
pathogenic strain SIVmac239, we were able to define transcrip-
tional events in memory cells at a time when a significant fraction
of those cells harbor virus.
Typically, determining the effect of HIV on cellular transcrip-
tion programs in vivo is made difficult by the paucity of infected
cells – during chronic infection, typically only one percent or less
of CD4 T cells are infected [9,10,11], and many of these may have
been infected with defective viruses unable to generate spreading
infections. However, recent studies of acute SIV infection [2] show
that as many as half of all CD4+ T cells can be infected at the peak
of the acute infection. Cells isolated at this time point provide a
unique window to evaluate the effect of SIV infection on cellular
gene activity.
In this study, we used the SIVmac239 infection model, which
allows us to assess the virus induced transcriptional changes in the
target cells at the peak of acute infection. We used microarray
analysis to assess these changes in flow cytometry sorted subsets of
peripheral blood CD4+ T cells from infected rhesus macaques in
contrast to their paired pre-infection status. We identify both
systemic transcriptional changes (i.e., also occurring in uninfected
cells), as well as changes selectively occurring in infected cells.
Among the latter include factors central to cell cycle transition,
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25684demonstrating that viral interference with the cell cycle is a critical
component during the establishment of a pathogenic infection in
vivo.
Results
SIV mac239 specifically targets CD4+ central memory
cells
SIVmac239 is a highly pathogenic virus that selectively targets
CD4+ central memory cells through obligate use of the CCR5 co-
receptor. Four Rhesus Macaques were infected with SIVmac239.
The peak of infection occurred at day 7 post infection as suggested
by the plasma viral load (Figure 1a). At this time point, we
confirmed the selective targeting of memory T cells by quantifying
the cell-associated viral load in different subsets (Figure 1b). By day
10 post infection, memory cells showed a 13-fold higher level of
gag DNA than naı ¨ve CD4 cells, and averaged 2.3 DNA copies per
cell. It was previously estimated that at the peak of infection
around 30–60 percent of the memory cells are infected and that
80% of these infected cells are eliminated during the next few days
[2]. Indeed, in agreement with published data, the relative number
of CD4+ central memory cells (as a portion of naı ¨ve CD4+ cells) at
day 10 post infection dropped 60% (Figure 1c). This suggests that
the targeted loss of this subset could be ascribed largely to direct
viral infection. Importantly, phenotypic analysis shows there is no
(up to day 10) or minor increase (days 14 and later) in the
activation state (expression of HLA-DR or CD38) or proliferation
state (expression of Ki-67) of the CD4 T cell compartment [12,13].
At these time points, a majority of infected cells are still in a
classical ‘‘resting’’ state.
Transcriptional analysis was performed on flow cytometry
sorted subsets of naı ¨ve and central memory CD4+ T cells along
with naı ¨ve CD8+ T cells on day 7 and 10 post infection, and
compared with paired samples for the same subsets isolated at day
0, i.e., pre-infection (Figure 2). Using this approach we could
determine the transcriptional changes that are associated with the
virus mediated transcriptional control in the targeted CD4+
memory T cell subset in contrast to those that arise a consequence
of a general inflammation (Figure 3). It is important to distinguish
the large variety of changes that arise due to a general
inflammation (i.e., in trans) from those that are mediated in
infected cells in cis. In our model, changes in naı ¨ve CD4 and CD8
T cells are mediated in trans; we hypothesize that the remaining
changes found in memory CD4 T cells are mediated in cis by viral
infection.
SIV infection induces systemic ‘‘Non-Targeted’’
transcriptional changes
The observation that resting CD4+ cells from viremic HIV+
individuals have a unique gene expression profile in comparison to
the same cells from either HIV+ aviremic or HIV
2 healthy
controls suggests that elevated viral replication is leading to altered
transcriptional profiles [14]. Indeed, plasma viral levels have been
shown to correlate well with immune activation in the host [15]
and are likely to affect the transcriptional expression levels seen in
CD4+ cells in HIV+ viremic individuals. Although microbial
byproducts may be the cause for immune activation in the chronic
setting of HIV [5,16] the contribution of the general inflammation
to the pathogenesis of HIV in acute phase has lately been
acknowledged [17,18] and it has been suggested that a pro-
inflammatory response may in fact facilitate the infectious process
[1,18,19], which is an interesting paradox.
In order to assess the scope of such systemic changes we
analyzed the gene expression changes that occurs post infection in
both the targeted (i.e. CD4+ central memory) and non-targeted
(Naı ¨ve CD4+ and CD8+) subsets and compared to the pre-
infection status. Note that by combining these subsets in this pre-
vs. post-infection analysis, transcriptional differences between
subsets are largely ignored. Clearly a profound change in the
expressional program, comprising thousands of genes, occurs at
day 7; declining somewhat towards day 10. An F-test with at a
false discovery rate of 0.02 and blocking for any bias from
individual differences associated to animal, population and day
produced a list of 2,914 genes (1602 up- and 1312 down-regulated)
associated to non-targeted changes (Figure S1 and Table S1).
Gene ontology and network analysis demonstrated that key
Figure 1. The peak of infection occurs at day 7 post infection. The plasma viral load assessed by a quantitative PCR measurement of viral RNA
copies in sampled peripheral blood (A). The major viral production is attributed to CD4+ central memory cells, which constitutes the main target for
the CCR5 tropic SIV mac239. At day 10 post infection the cell associated viral load is 13 fold higher in the central memory cells compared to the naive
CD4+ cells, as assessed by quantitative PCR for integrated gag DNA (B). A preferential selective loss of central memory cells occurs over the course of
the infection. Over half of the central memory cells are lost at day 10 post infection, illustrated here as the percent change in the ratio of central
memory cells over naive CD4+ T cells; assessed by flowcytometry (C).
doi:10.1371/journal.pone.0025684.g001
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responses, antigen presentation and regulation of cell death (data
not shown). In the list of down-regulated genes gene ontology
analysis indicates that the most significantly changed molecular
functions associated to this list are cell death/apoptosis (data not
shown).
The suggested inflammation-mediated upregulated gene ex-
pression constituted in large what are recognized as interferon-
stimulated genes (ISG) [20]. A number of prototypic ISGs were
upregulated by the SIV infection (Table 1) and demonstrated a
clear response to inflammation [21,22,23]. Several of the ISGs are
involved in antiviral responses (see Tables 1 and S1), including
MX1, MX2, ISG15 (G1P2), ISG20, IFIT1, IFIT3, IFI27, IFI44,
ADAR, PML, TRIM22 [24] as well as non-TLR innate immunity
regulators such as DDX58, IFIH1 and LGP2 which responds to
viral replication [25]. Many of the genes observed in the non-
targeted changes have been reported in the NCBI ‘‘HIV-1,
Human Protein Interaction Database’’, and among these are
several that are induced by HIV-1 Tat alone [26] (see Table S1). A
number of factors in this list are clearly antiviral, but several could
also be defined as facilitators of infection, such as AGFG1, AP2B1,
CUL5, HIVEP1, IPO7, KPNA1, KPNA5, KPNA6, KPNB1,
PML, SMAD3, SMAD4, SP1, SUPT4H1, TAF8, TOP1,
XRCC6.
Figure 2. Cell sorting scheme. Flowcytometric cell sorting was used to isolate T cell subsets from each animal at day 0, and at day 7 and day 10
post infection. Subsets of naive and central memory CD4+ T cells and naive CD8+ T cells were sorted using markers to selectively isolate viable
CD142 CD3+ cells subsetted as CD4+ CD28+ CD952 CD45RA+ CCR7+ naive CD4+ T cells and CD4+ CD28+ CD95+ CD45RA2 CCR7+ central memory
CD4+ T cells and further CD8+ CD45RA+ CCR7+ CD28+ CD952 naive CD8+ T cells (see orange highlighted box). The general phenotypic features
defined by these markers were maintained over the course of the infection (day 0 – day 10). Arrows indicates the gating strategy for selecting each
subset to be sorted. This is a representative figure for one of the four animals (DA9A). See Figure S2 for the profiles of all 4 animals.
doi:10.1371/journal.pone.0025684.g002
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CD4+ central memory target population
The loss of memory cells seen during acute SIV infection [2]
significantly exceeds the fraction of activated T-cells normally
thought to support productive virus. The depletion of otherwise
resting cells thus evokes questions as to the mechanism for this
specific depletion. We analyzed the gene expression changes that
occur as a result of the infection in the target subset, excluding
those changes that were already accounted for above (in the non-
targeted cells) and in comparison to the paired pre-infection
subsets. These remaining changes include nonspecific (e.g.,
inflammatory) but selective to CD4 memory cells as well as those
changes effected by the virus itself. As noted below, some of these
changes are unlikely to be subset-specific inflammatory responses
but rather represent plausible virus-mediated changes in tran-
scriptional profiles.
A robust F-test (FDR,0.05 controlling for bias from animal,
population and day) of the transcriptional changes occurring in the
CD4+ central memory target subset and not in the non-targeted
subsets, generated a list of genes of which 35 were up-regulated
and 78 were down-regulated (Figure 4a and Table S2). The target
transcriptional changes were validated by the expression of SIV
genes (env, nef, rev and tat) demonstrating that the observed
changes are attributed to the infection of the target subset. In
addition to the SIV genes a number of endogenous host genes
were part of the list (Figure 4a) and to further understand the
potential biologic associations between these genes we applied an
Isomap distribution to this gene list; analyzed by principal
component analysis [27]. The Isomap analysis is assumed to
capture biologic similarities and was used to get a better
understanding of the relationships between the genes (Figure 4b).
This analysis highlighted several genes that where closely
associated to the SIV genes in the isomap 3-dimensional
distribution. When increasing the stringency of the F-test to
FDR,0.01 (controlling for bias from animal, population and day)
the analysis showed a much tighter association of these genes to an
infection-mediated transcriptional regulation (Figure 4c). Among
the more closely associated endogenous genes where TAF7 and
ZNF300 along with a number of poorly annotated and described
genes. On the other hand both TAF7 and ZNF300 are more well-
defined genes. The finding of TAF7 is interesting in respect to its
documented functional association to Tat [28] and the ZNF300 is
likely a transcriptional repressor as it belongs to the KRAB
domain containing C2H2 family of zinc binding proteins, which
are archetypical repressors [29].
In the list of genes that are down-regulated in the targeted
response are, of note, a large number of cell cycle associated genes.
26 out of the 78 down regulated genes are associated with cell
cycle functions and several of them are critical for the mitotic
program and different levels of checkpoint control functions
(Figure 4a and Table S2). These include the two components of
the Maturation Promoting Factor (MPF), Cyclin B2 (CCNB2) and
CDK1/cdc2 (CDC2), which is the master regulator of the mitotic
program (illustrated in Castedo et al. [30]). In addition are found
key molecules of the DNA Structure Checkpoint, Chk1 (CHEK1),
which regulates the initiation of the MPF [30]. Also found are
factors controlling transitional events of mitosis such as Cdc20
(CDC20), BubR1 (BUB1B) and UBE2C (UBE2C) which partici-
pates in the mitotic checkpoint, regulating the Anaphase
promoting complex (APC) and facilitating the destruction of
Cyclin B in the metaphase/anaphase of the cell cycle [31]. Several
other molecules participating in mitosis are also present in this list,
such as, the centromer protein M (CENPM) and N (CENPN) [32]
along with CCNE1, CDCA5, CDT1, CEP55, MKI67, NUSAP1,
Figure 3. Schematic figure illustrating factors affecting the transcriptional changes in the three different sorted T cell subsets over
the course of the infection.
doi:10.1371/journal.pone.0025684.g003
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The concerted regulation of all these functionally related genes
suggests a specific transcriptional repression mechanism aimed at
modifying cell cycle control in vivo.
The virus-induced repression of cell cycle genes suggests
a virus targeted E2F
In order to understand potential common regulatory targets
among the repressed cell cycle genes we analyzed the 1000 base-
pair promoter region for shared regulatory sequences among all 26
down regulated cell cycle genes. By comparing to a background set
of 41,906 human promoters and running against known cell cycle
associated transcription factor binding sites the analysis suggested
a highly significant association of E2F matrices among these genes
(Table 2). 8 out of the 10 most significant matrix associations were
all E2F binding sites, especially E2F1 (Table 2); which suggests a
common regulatory mechanism among these 26 genes. Together,
these results indicate that infection by SIV targets E2F in a
Table 1. Prototypic ISGs upregulated in the non-targeted response.
Number of probes in list
Tat induced (Izmailova et al.,
2003) Antiviral
HIV-1, Human Protein
Interaction Database
CIC 1
EIF2AK2 3xx x
EPSTI1 3
GBP1 7x
GBP2 3x
ICAM1 2 x
IFI16 1x x
IFI27 1xx x
IFI35 1x x
IFI44 2xx x
IFI6 (G1P3)1 x
IFIH1 1x
IFIT1 1x
IFIT1L 1
IFIT3 3xx x
IFITM1 2x x
IFITM3 4
IRF2 1 x
IRF7 1xx x
IRF9 1x
ISG15 (G1P2)1 x x x
ISG20 1xx x
LGALS3BP 1
LY6E 1
MX1 1xx x
MX2 2x
OAS1 3x x
OAS2 3x x
OAS3 3x x
OASL 1x
RSAD2 2x
SAMD9L (C7orf6)2
SERPING1 1
SP110 2x x
STAT1 4x x
STAT2 2
TAP1 1x x
TNFSF10 2xx x
UBE2L6 1
doi:10.1371/journal.pone.0025684.t001
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programming within infected cells.
Discussion
To characterize the effects of SIV infection on the cellular
transcription in vivo, we isolated T cell subsets from NHP during
the acute phase of the infection. Four animals wereinfected with the
highly pathogenic molecular SIVmac239 and the response to the
infection was assessed after 7 and 10 days post infection and
compared to measurements made pre-infection. We took advantage
of the fact that SIVmac239 is CCR5-tropic and infects primarily
memory CD4 T cells. This enabled us to specifically address
questions as to the specific effect of the virus on its target cells (i.e.,
memory CD4 T cells) in contrast to effects mediated through
generalized inflammation (as revealed by non-targeted cells such as
naı ¨veCD4ornaı ¨veCD8T cells).Fromthespecified time points,we
used flow cytometric sorting to purify these subsets of T cells,
followed by gene expression profiling, to identify those genetic
programsthatareselectivelymodifiedinthevirally-targetedsubsets.
Figure 4. Targeted changes affecting the CD4+ central memory cells. A. Heat map representation of a total set of 113 up and down
regulated changes returned by the robust F-test (FDR,0.05). 35 genes are upregulated and 78 genes are downregulated. B. Isomap representation of
PCA 1, 2 and 3 of upregulated targeted changes returned by the F-test (FDR,0.05) illustrating how sets of genes forms distinct biologic networks. C.
Representation of the more stringent F-test (FDR,0.01) showing a set of 36 up and down regulated genes (8 and 28 respectively). The heat map
representations display data normalized to a mean of 0. Hierarchical clustering was performed on the smallest maximum pair wise distance
(maximum linkage).
doi:10.1371/journal.pone.0025684.g004
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try to understand the complexity of HIV disease, both in vivo
[14,33,34,35,36,37,38,39,40,41] and in vitro [42,43,44,45,46].
However, as HIV/SIV infection generates such a profound innate
immune response, transcriptional changes occurring in response to
the viral infection risk being masked by transcriptional programs
associated to an innate antiviral response. This is particularly true
in the setting of chronic infection, where the fraction of infected
cells (,1%) is so low that virus-mediated effects are difficult to
measure. Many of these studies therefore fail to resolve any viral
induced transcriptional changes in endogenous host genes.
Little is known about viral mediated transcriptional regulation
of endogenous genes. The predominant way of viral control of host
cell events is suggested through protein-protein interactions from
factors like Nef, Vpr and Tat [18] and the concept of a virus-
mediated transcriptional regulation of endogenous host genes is
largely unexplored. However, a number of mainly in vitro studies
have suggested that the virus may indeed affect host endogenous
transcription [42,46,47,48,49], but to what extent this control is a
direct or indirect virus-mediated regulation is unknown. Many
previous studies addressing questions of viral mediated transcrip-
tional control of host genes have also been limited either by the
fact that, firstly, in the in vivo setting only a small number of CD4+
T cells are at a given time infected by the virus [9], secondly, a
large part of the transcriptional events occurring in an HIV/SIV
setting are a consequence of an innate immune- or a cellular
antiviral response. We wished to avoid artifacts introduced by ex
vivo culture (or the use of cell lines); thus, we used an in vivo model
system in which a large fraction of the target population is infected
at the peak of infection. We controlled for non-HIV-induced
transcriptional changes by comparing the paired non-infected
CD4+ subset as well as a CD8+ subset.
Transcriptional regulation in uninfected cells
It is suggested by in vitro studies that HIV viral RNA triggers a
TLR7 dependent IFN-a secretion by pDCs [50,51] leading to a
natural response to the viral infection. This pro-inflammatory
response will consequently give rise to profound effects on the
immune system, which was readily evident in our analysis.
However, many secondary effects attributed to HIV-derived
factors such as Nef and Tat [52] may also give rise to a multitude
of systemic bystander effects. In our analysis, the aggregated
response from these indirect effects of SIV infection resulted in a
transcriptional change of 2,914 genes, 1,602 upregulated and
1,312 downregulated. Although a TLR7 dependent induction of a
type I IFN response is likely to occur, type I IFNs are suggested not
to fully account for all ISG changes in HIV [35]. In fact, both
gp120 [53,54] and Tat [26] have been implicated in the induction
of an interferon response. Izmailova et al. [26] reports of Tat
mediated expression of ISGs in immature DCs and several of the
Tat induced ISGs observed in their study are overlapping with our
findings of non-targeted changes. Whether this is a functionality of
Tat that have evolved to facilitate the infection can only be
speculated, but it has been proposed that the pro-inflammatory
response induced by the viral infection may promote the infectious
process [1,18,19] and that factors participating in this response
could facilitate the productive infection of target cells. We
observed a number of factors in the innate response that have
been shown to play important roles for the viral infection of the
target cell, factors that are involved in HIV-1 endocytosis, nuclear
import, integration, transcription, nuclear export and inhibition of
antiviral factors (e.g. AGFG1, AP2B1, CUL5, HIVEP1, IPO7,
KPNA1, KPNA5, KPNA6, KPNB1, PML, SMAD3, SMAD4, SP1,
SUPT4H1, TAF8, TOP1, XRCC6). In this respect it is also
interesting to note the induction of IRF2, which can be linked to
the type I interferon response and is exploited by other viral
pathogens. IRF2 has recently been demonstrated as a transacti-
vator in the early activation of HPV-16 [55]. HPV-16, akin to
HIV-1, is known to regulate early viral transcription by conserved
interferon response elements in the viral promotors, binding both
IRF1 and IRF2 [56,57]. As IRF1 has been demonstrated to be
required for NFkB transcriptional activity at the HIV-1 long
terminal repeat enhancer via interferon response element binding
[58] a functional overlap with IRF2 similar to what is seen in
HPV-16 could also be suggested for HIV-1. This functional
involvement of IRF2 on HIV-1 transcription would thus represent
a clear connection to a type I interferon driven regulation of HIV-
1.
Transcriptional regulation in SIV infected cells
From a conceptual point of view the transcriptional control of
endogenous host genes can be mediated by either a direct
mechanism (i.e. by a direct transcriptional control of the gene,
where Tat would be the most likely factor) or an indirect
mechanism (i.e. by secondary transcriptional control, through
activation or inhibition of transcription factors). Several studies
Table 2. Transcription factor binding site analysis for the 26 down regulated cell cycle genes.
Matrix name P-value Recognized factors
V$E2F_02 1.75610
27 E2F-1, E2F-2, E2F-3, E2F-3B, E2F-3a, E2F-4, E2F-5, E2F:DP
V$E2F_Q4_01 1.90610
26 DP-1, E2F, E2F-1, E2F-3, E2F-3B, E2F-3a, E2F-4, E2F:DP, E2F:DP:E4
V$E2F1_Q4_01 3.01610
27 DP-1, E2F, E2F-1, E2F-3, E2F-3B, E2F-3a, E2F-4, E2F:DP, E2F:DP:E4
V$E2F_Q6_01 1.15610
27 DP-1, E2F, E2F-1, E2F-1:DP-1, E2F-3, E2F-3B, E2F-3a, E2F-4, E2F-7, E2F:DP, E2F:DP:E4
V$E2F_Q3_01 7.27610
27 DP-1, E2F, E2F-1, E2F-3, E2F-3B, E2F-3a, E2F-4, E2F:DP, E2F:DP:E4
V$E2F1_Q6_01 3.19610
219 E2F-1
V$E2F_Q2 2.82610
251 DP-1, E2F, E2F-1, E2F-3, E2F-3B, E2F-3a, E2F-4, E2F:DP, E2F:DP:E4
V$E2F1_Q3_01 2.42610
221 E2F-1
V$NFY_Q6_01 5.98610
25 CBF(2), CBF-A, CBF-B, CBF-C, CP1, NF-Y, NF-Y9, NF-YA, NF-YA isoform-1, NF-YA isoform-2, NF-YB, NF-YC,
NF-YC-3
V$E2F_01 5.43610
24 E2F-1, E2F:DP
Note: Analysis of the 1000 base-pair upstream region was performed for the 26 down-regulated cell cycle genes. The top 10 binding site matrices are shown.
doi:10.1371/journal.pone.0025684.t002
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[26,47,48,59,60] and Nef [61,62,63] in various in vitro systems. It
is difficult to draw any clear conclusions from these studies and to
what extent the reported gene changes in these studies are also
replicated in the in vivo setting. In fact, there is very little overlap
between reported genes in any of these studies and the regulation
observed in our system. Furthermore, as Tat appears to have a cell
cycle regulated transcriptional activity [64,65] it has been
suggested that transcription of endogenous genes regulated by
Tat occurs in the G2 phase of the cell cycle, possibly also requiring
Vpr induced cell cycle arrest [64]. One of the endogenous genes
induced by the virus in our study was TAF7, and as TAF7 is
involved in the fundamental regulation of RNA polymerase II
mediated transcription this is a notable finding. TAF7 is a TATA-
binding protein (TBP) associated factor (TAF), which regulates the
acetyltransferase activity of TAF1 (a regulator of the transcription
preinitiation complex of the basal transcription factor) [66]. It is
suggested that TAF7 functions as a check-point regulator of
transcription [67] and it is known that TAF7 interacts with the P-
TEFb elongation complex, consisting of Cyclin T1 and CDK9,
also regulating elongation [28]. TAF7 function also seem to be
associated to the G2/M transition [68]. Analogous to Tat, TAF7
also inhibits MHC class I expression in vivo, and the two factors
share several functional properties [28,66,67]. Together this
demonstrates that TAF7 is a transcriptional checkpoint regulator,
controlling transcription during the G2/M transition of the cell
cycle and having a role in the regulation of MHC class I
expression. TAF7 was recently demonstrated to also regulate the
acetyl transferase activity of CIITA [69], which is the key factor in
TAF1-independent transcription of MHC class I and II in
response to infection. One could therefore speculate whether
TAF7 is utilized, by the virus, in the control of MHC antigen
presentation during infection; and does this also extend to the
control of the cell cycle program? In our study we observe
transcriptional repression of key cell cycle genes associated to
central regulators of the G2/M transition. Our results further
suggest that many of the repressed genes are regulated by the E2F-
transcription factor family and especially E2F1. As E2F1 itself is
transactivated by the basal transcription factor [70], TAF7
mediated acetyl transferase regulation may thus impact on the
transcription of the E2F1 target genes. However, another
explanation for the down regulation of the central cell cycle
regulators may be cytoplasmic sequestration of E2F1. It has
recently been suggested that E2F1 may have a role in HIV-
induced neuronal damage where it was found that a predominant
cytoplasmic localization of E2F1 may account for this neurotox-
icity, simply by not being able to transactivate its target genes [71].
The specific down regulation of several E2F1 target genes in the
infected CD4+ central memory cells may suggest a similar
mechanism in these cells and could also explain the induction of
cytotoxic events in infected cells.
In summary, we identified sets of host genes that exhibit
significantly altered expression in vivo, during acute SIV infection
of rhesus macaques. By purifying T cell populations that are nearly
purely uninfected and those cells that are infected at a high rate,
we were able to distinguish regulatory effects arising in trans (from
inflammatory processes) from those likely arising in cis (effected by
virus in the cell). Among the former are large groups of interferon-
responsive genes, as expected. The latter group contains a large
number of cell cycle-associated genes. This suggests that a critical
component of SIV cytopathicity in vivo is a consequence of altered
cell cycle regulation. These regulatory events may also underlie the
basic mechanism accounting for the productive infection and
elimination of a large number of resting, unactivated T cells in
vivo.
Materials and Methods
Virus and Animals
The origin and preparation of the tissue culture-derived
SIVmac239 stocks from molecular clones have been described
previously [72,73]. Rhesus macaques (Macaca mulatta) were
maintained in accordance with the guidelines of the Committee on
Care and Use of Laboratory Animals [74] and were housed in a
biosafety level 2 facility; biosafety level 3 practices were followed.
All studies were approved by NIAID and VRC Institutional
Animal Care and Use Committees. Four healthy Rhesus
Macaques (Macaca mulatta), DB13, DA9A, DBAW and DBE1
(numbered 1, 2, 3 and 4 respectively) were inoculated intrave-
nously with the molecular clone SIVmac239 at 1000 times the
50% tissue culture infectious dose (1000 TCID50). The animals
were sampled for peripheral blood at day 7 and day 10 post
infection for clinical blood cell count and plasma viral load as well
as for T cell isolation by flow cytometry cell sorting.
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol (LMM32) was approved by National Institute of Allergy
and Infectious Diseases, Division of Intramural Research Animal
Use and Care Committee (PHS Assurance #A4149-01). Animals
were housed and procedures were performed in accordance with
all local, state and Federal laws governing in vivo research, in
facilities fully accredited by the Association and Accreditation of
Laboratory Animal Care International (AAALAC). All procedures
were performed under appropriate anesthesia to alleviate pain and
minimize suffering as published by the National Institutes of
Health Animal Resource Advisory Committee (ARAC).
Cell associated viral load and plasma viral load
T-cell-associated viral DNA was measured by a quantitative
PCR assay for SIV gag using a Applied Biosystems 7900HT
instrument (Applied Biosystems), and using SIV gag primers and
probe as described previously [2]. Viral-RNA levels in plasma
were determined by real-time reverse transcription-PCR (ABI
Prism 7700 sequence detection system; Applied Biosystems) as
previously reported [75].
Flow cytometry analysis
EDTA-treated blood samples were stained for flow cytometric
analysis using combinations of the following fluorochrome-
conjugated mAbs: CD3-PE (clone SP34-2), CD4-PerCP-Cy5.5
(clone L200) CD8-PerCP (clone SK1), CD28-FITC (clone
CD28.2), CD95-APC (clone DX2), obtained from BD Biosciences
Pharmingen and analyzed by four-color flow cytometry (FACS-
Calibur, BD Biosciences Immunocytometry Systems). CD4
percentages were multiplied by lymphocyte counts from standard
CBC analyses on the same blood draw to determine absolute CD4
counts.
Fluorescence activated cell sorting (FACS) was used to isolate
Naı ¨ve CD4+, Central memory CD4+ and Naı ¨ve CD8+ T cells.
The subsets were sorted on the basis of their expression of CD14,
CD3, CD4, CD8, CD28, CD95, CD45RA, CCR7 and the
viability label Propidium Iodide (PI). The following in house
produced reagents were used: CD4-FITC (clone M-T477) CD14-
PE (clone M5E2), CD8-QD705 (clone RPA-T8), CD28-QD605
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reagents were acquired from Beckman Coulter: CD45RA-PETxR
(clone 2H4LDH11LDB9) and CD27-APCA700 (clone
1A4CD27); and from BD Pharmingen: CD3-APCCy7 (clone
SP34-2) and CD95-APC (clone DX2).
Cells were sorted in an aerosol contained Biosafety level 3
setting on a special order FACS Aria (BD) with Blue, Red and
Violet lasers. At least 2610
6 cells were sorted from each subset and
the sorted cells were collected in 10% serum at 4uC.
RNA isolation and microarray sample handling
The total RNA was isolated using the RNAqueousH-4PCR
isolation kit (Ambion) following the standard protocol. Briefly, cells
collected from the cell sorter were pelleted at 8606g, the sheath
buffer was aspirated off and the cells were lysed in the supplied
lysing/binding solution and subsequently mixed with 64%
ethanol. This mix was left over night at 220uC. The RNA
isolation was then carried out as stated in the protocol supplied
with the kit. A quality analysis of the isolated total RNA was
performed on a Bioanalyzer (Agilent) and the material typically
had a 260/280 ratio above 1.7. The Affymetrix One-Cycle cDNA
Synthesis Kits (Affymetrix) was used to prepare the material for
hybridization to the Rhesus Macaque gene chips according to the
provided protocol. Hybridized chips were scanned on an
Affymetrix Scanner.
Data analysis
The raw data was quality assessed by principal component
analysis, and two samples with outlying behavior were removed
from the analysis. Analyses were performed using the Qlucore
Omics Explorer (Qlucore AB, Lund, Sweden). All samples passing
the quality assessment were imported into Qlucore Omics
Explorer as RMA normalized data.
Annotations
The Affymetrix Rhesus Macaque gene chip genome definitions
were fairly rudimentary annotated. At the time of analysis only
25,115 out of 52,865 probes were fully annotated with an official
gene symbol (annotations were from Affymetrix Rhesus Macaque
na28.annot.20090430). Based on any available annotation data we
managed to infer gene symbols for an additional 18,202 probes;
6,913 probes had no annotation at all at the time of analysis.
Within the chip 831 probes for genes other than Rhesus Macaque
are present. A number of different pathogens are represented such
as several herpes virus and hepatitis virus genes along with 17 SIV
and 6 SHIV genes. The SIV genes were used as a positive control
for infection in our analysis.
Non-targeted changes
In order to analyze non-targeted changes 11 samples were
included in the pre infection control group and 23 samples were
included in the post infection group affected by non-targeted
changes. The data was analyzed in the Qlucore Omics Explorer
(Qlucore, Lund, Sweden) using an F-test with a false discovery rate
at FDR,0.05 and controlled for bias from the animal, population
and day parameters, which is achieved by eliminating these factors
in the general linear model that the software sets up to test the null
hypothesis against the alternative hypothesis, where the alternative
hypothesis is modeled by the eliminated factors and the test factor.
Targeted changes
For the analysis of targeted changes all samples targeted by the
virus were assessed by the Qlucore Omics Explorer using an F-test
at FDR,0.05 and FDR,0.01 and controlling for any bias from
animal, population and day. 8 samples constituted the group of
targeted samples, consisting of CD4+ central memory cells at day
7 and 10 post infection. The control samples, not infected by the
virus included all other subsets and time points and added up to 26
samples in total.
Functional analysis
Functional, gene ontology and network analysis was performed
in the Ingenuity Pathway Analysis database tool (http://www.
ingenuity.com/).
Promoter analysis
Promoter analysis was performed using the BIOBASE ExPlain
gene expression analysis system (www.biobase-international.com),
mining the TRANSFAC database for transcription factor binding
sites. A 1000 base-pair upstream promoter region was analyzed for
known cell cycle associated transcription factor binding sites using
a background set of 41,906 human promoters.
Supporting Information
Figure S1 Heat map representation showing hierarchi-
cal clustered transcriptional changes as a consequence
of the non-targeted response based on an F-test at a false
discovery rate of 0.02 and blocking for any bias from
individual differences associated to animal, population
and day. The analysis generated a list of 2,914 genes (1602 up-
and 1312 down-regulated) associated to non-targeted changes.
(PDF)
Figure S2 Cell sorting scheme for all 4 animals at day 0,
and at day 7 and day 10 post infection.
(PDF)
Table S1 Non-targeted changes following SIV infection.
An F-test at a false discovery rate of 0.02 and blocking for any bias
from individual differences associated to animal, population and
day produced a list of 2,914 genes associated with non-targeted
changes. Tab 1 shows 1,602 upregulated genes and Tab 2 shows
1312 downregulated genes. Tab 1 columns are ‘‘Probeset ID’’;
‘‘Alternate target description’’ (identifies HIV gene names); ‘‘Gene
symbol (inferred)’’ (see Material and Methods for details); ‘‘Gene
Symbol’’ (as per original annotation ‘‘na28.annot.20090430’’); and
four columns identifying published characteristics: ‘‘Antiviral’’
(refers to published antiviral properties); ‘‘HIV-1, Human Protein
Interaction Database’’ (refers to the NCBI data base); ‘‘Facilita-
tors’’ (refers to published HIV infection facilitating activities), and
‘‘Tat induced’’ (refers to genes reported to be induced by HIV
Tat). Tab 2 columns have the same information for genes that are
upgregulated following SIV infection.
(XLS)
Table S2 Targeted changes following SIV infection. An
F-test at a false discovery rate of 0.05 and blocking for any bias
from individual differences associated to animal, population and
day produced a list of 113 genes associated to transcriptional
changes occurring in the CD4+ central memory target subset and
not in the non-targeted subsets. Tab 1 shows 35 upregulated genes
and Tab 2 shows 78 downregulated genes. Tab 1 columns are
‘‘Probeset ID’’; ‘‘Figure annotation’’ (refers to relevant annota-
tion); ‘‘Gene symbol (inferred)’’ (see Material and Methods for
details). Tab 2 columns also include ‘‘Cell cycle’’ (refers to role in
cell cycle, where ‘‘+’’ indicates role in cell cycle and ‘‘?’’ indicated
possible role in cell cycle).
(XLS)
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